Coccidian vaccine immunopotentiation suspending agent and preparation method thereof
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A chicken coccidiosis and suspending agent technology, applied in the direction of medical preparations with non-active ingredients, medical preparations containing active ingredients, and pharmaceutical formulas, etc., can solve the problems of shortening the period of immune production, synergizing, and non-existence
Inactive Publication Date: 2015-09-02
SHANXI AGRI UNIV
View PDF3 Cites 1 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
The technology of coccidia vaccine suspending agent has been documented, for example, Chinese patent 200510036004.6 discloses a kind of coccidia vaccine suspending agent and its processing technology to be prepared from following raw material and technology: its component content (by suspending agent 100% by weight) carboxymethyl cellulose 5%-20%, air-dried powder 0.5%-3%, and the rest are oligosaccharides, which can suspend coccidia oocysts in water for 6 hours without sedimentation, but have no synergistic effect and the effect of shortening the period of immune production
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0078]Preparation of chicken coccidiosis vaccine immune synergistic suspension.
[0079] Get the following raw materials in parts by mass, carbomer 934P 0.05, hydroxypropyl methylcellulose 0.15, astragalus polysaccharide 1, chitosan 0.5, poloxamer 0.9, carbomer, hydroxypropyl methylcellulose, Stir astragalus polysaccharide, chitosan, and poloxamer until uniform.
Embodiment 2
[0081] Preparation of chicken coccidiosis vaccine immune synergistic suspension.
[0082] Get the following raw materials in parts by mass, carbomer 934P 3, hydroxypropyl methylcellulose 4, astragalus polysaccharide 55, chitosan 30, poloxamer 35, and carbomer, hydroxypropyl methylcellulose, Stir astragalus polysaccharide, chitosan, and poloxamer until uniform.
Embodiment 3
[0084] Preparation of chicken coccidiosis vaccine immune synergistic suspension.
[0085] Take the following raw materials in parts by mass, carbomer 934P 0.05, hydroxypropylmethylcellulose 4, astragalus polysaccharide 1, chitosan 30, poloxamer 0.9, and carbomer, hydroxypropylmethylcellulose, Stir astragalus polysaccharide, chitosan, and poloxamer until uniform.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Property
Measurement
Unit
viscosity
aaaaa
aaaaa
Login to view more
Abstract
The invention discloses a coccidian vaccine immunopotentiation suspending agent which comprises the following raw materials in parts by mass: 0.05-3 parts of Carbomer934P, 0.15-4 parts of hydroxypropyl methyl cellulose, 1-55 parts of astragalus polysaccharide, 0.5-30 parts of chitosan, and 0.9-35 parts of poloxamer. A preparation method of the coccidian vaccine immunopotentiation suspending agent comprises the following steps: respectively taking Carbomer, 4 parts of hydroxypropyl methyl cellulose, astragalus polysaccharide, chitosan and poloxamer in parts by mass, stirring and uniformly mixing at normal temperature, and storing at normal temperature. A using method of the coccidian vaccine immunopotentiation suspending agent comprises the following steps: at first, feeding 1 part of the coccidian vaccine immunopotentiation suspending agent into 25 parts of clear water, stirring for 5-10 minutes, diluting into a suspending solution, then adding each part of live coccidian vaccine into 6 ml of the suspending solution, stirring and uniformly mixing, and drinking the mixture freely by chicken. The suspending agent is lasting in suspending effect, and efficient in immune effect, can shorten the immunifacient stage, and achieves the effects that water is continuously fed before immunization, the immunizing dose is uniform, and the immunifacient stage is short.
Description
technical field [0001] The invention belongs to animal vaccine suspending agent, in particular to a chicken coccidiosis live oocyst vaccine immune synergistic suspending agent used for drinking water immunization. Background technique [0002] Chicken coccidiosis (coccidiosis) is a protozoan disease caused by one or more of the nine species of Eimeria coccidiosis parasitizing in intestinal epithelial cells, mainly caused by diarrhea, intestinal damage or bloody stool. features. It is a common and serious disease. Chicken coccidiosis occurs in almost all chicken farms. Intensive chicken farms are the most important places where coccidiosis breaks out. The incidence of coccidiosis is 50% to 70%, and the mortality rate is 20% to 30%. In severe cases, it can be as high as 80%. Among all chicken diseases, the incidence of coccidiosis is the highest, accounting for about 20%. Even the diseased chickens that have tolerated it can not recover to the level before the infection, a...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.